Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) Stock

About Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Pharmaceuticals Holding Co., Ltd. functions as an investment holding company deeply involved in various facets of China's pharmaceutical and healthcare sectors. Its primary activities include the research, development, production, distribution, and retail of a diverse array of medical and health-related products. The company organizes its operations across four segments: Production, Distribution, Retail, and Others. Its extensive product portfolio encompasses chemical and biochemical medications, traditional Chinese medicines, health products, and medical devices. These target a broad spectrum of therapeutic areas, such as oncology, cerebrocardiovascular conditions, central nervous system disorders, general infections, immunology, digestive and metabolic diseases, and respiratory ailments, offering approximately 700 different drug formulations. Beyond manufacturing, Shanghai Pharmaceuticals provides comprehensive pharmaceutical supply chain solutions. This includes distribution, warehousing, logistics, and various value-added services catering to drug manufacturers and healthcare providers like hospitals, other distributors, and retail pharmacies. The company also manages a substantial retail footprint, operating around 2,000 chain pharmacies across 24 provinces, complemented by an online drug business. Furthermore, its service offerings extend to consulting, asset management, clinical trial support, medical aid programs, educational initiatives for patients and physicians, e-prescription management, and the development of remote and cloud hospital solutions. Established in Shanghai in 1994, where it maintains its headquarters, Shanghai Pharmaceuticals Holding Co., Ltd. operates as a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.

Shanghai Pharmaceuticals Holding Co., Ltd is headquartered in CN.

Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF) stock trades at $1.46 with a market capitalization of $8.46B. The stock is valued at a price-to-earnings (P/E) ratio of 10.56, price-to-book of 0.80, price-to-sales of 0.21. Over the past 52 weeks the stock has ranged between $1.46 and $15.70, and currently trades 90.7% below its 52-week high. It pays a dividend yielding 6.85%.

On profitability, Shanghai Pharmaceuticals Holding Co., Ltd generates a return on equity (ROE) of 7.64%, return on capital employed of 10.29%, an operating margin of 3.53%, a net profit margin of 2.02%.

Official website: www.sphchina.com